JP2006523083A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006523083A5 JP2006523083A5 JP2004544846A JP2004544846A JP2006523083A5 JP 2006523083 A5 JP2006523083 A5 JP 2006523083A5 JP 2004544846 A JP2004544846 A JP 2004544846A JP 2004544846 A JP2004544846 A JP 2004544846A JP 2006523083 A5 JP2006523083 A5 JP 2006523083A5
- Authority
- JP
- Japan
- Prior art keywords
- cells
- abt2
- fcs
- rpmi
- resuspended
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004027 cells Anatomy 0.000 description 7
- 210000004011 Plasma Cells Anatomy 0.000 description 5
- 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 4
- 102000004965 antibodies Human genes 0.000 description 4
- 108090001123 antibodies Proteins 0.000 description 4
- 238000010367 cloning Methods 0.000 description 3
- 229920002676 Complementary DNA Polymers 0.000 description 2
- 210000003743 Erythrocytes Anatomy 0.000 description 2
- 239000000427 antigen Substances 0.000 description 2
- 102000038129 antigens Human genes 0.000 description 2
- 108091007172 antigens Proteins 0.000 description 2
- 238000004166 bioassay Methods 0.000 description 2
- 239000011248 coating agent Substances 0.000 description 2
- 238000000576 coating method Methods 0.000 description 2
- 238000003757 reverse transcription PCR Methods 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 1
- 102000018358 Immunoglobulins Human genes 0.000 description 1
- 108060003951 Immunoglobulins Proteins 0.000 description 1
- 210000003734 Kidney Anatomy 0.000 description 1
- 108020004999 Messenger RNA Proteins 0.000 description 1
- 210000003324 RBC Anatomy 0.000 description 1
- 108010090804 Streptavidin Proteins 0.000 description 1
- 238000007413 biotinylation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 239000012595 freezing medium Substances 0.000 description 1
- 210000002865 immune cell Anatomy 0.000 description 1
- 238000010820 immunofluorescence microscopy Methods 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 229920002106 messenger RNA Polymers 0.000 description 1
- 238000003752 polymerase chain reaction Methods 0.000 description 1
- 238000003118 sandwich ELISA Methods 0.000 description 1
- 230000003248 secreting Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Description
プラズマ細胞の作製:先のアッセイにより該当免疫グロブリンを分泌するB細胞クローンを含むと同定された単一微量培養ウェルの内容物を回収した。100−1000μlピペットマンを使用し、37C RPMI(+10%FCS)を加えることによりウェルの内容物を回収した。細胞をピペッティングにより再懸濁した後に別の1.5mlエッペンドルフチューブに移した(最終容量500〜700μl)。細胞をマイクロ遠心機で1500rpm(240rcf)にて2分間室温で遠心した後、試験管を180°反転させ、再び2分間1500rpmで遠心した。凍結培地を吸引除去し、免疫細胞をRPMI(10%FCS)100μlに再懸濁した後、遠心した。RPMI(10%FCS)によるこの洗浄を繰返し、細胞をRPMI(FCS)60μlに再懸濁し、使用時まで氷上保存した。
プラークアッセイ結果:二次検出試薬単独(0/4)に比較してコーティングを検出するためにMAB307を使用して免疫蛍光顕微鏡測定によりコーティングを定性測定した処、非常に高品質(4/4)であることが判明した。ストレプトアビジンのみをコーティングした赤血球でMAB307抗体を使用した場合にはシグナルは検出されなかった(0/4)。次にこれらの赤血球を使用して表4に示す14個のウェルから抗原特異的プラズマ細胞を同定した。抗原特異的プラズマ細胞を回収する顕微操作後に、可変領域遺伝子をコードする遺伝子を単一プラズマ細胞でRT−PCRにより回収した。
発現。単一プラズマ細胞の単離後に、mRNAを抽出し、逆転写PCRを実施してcDNAを作製した。ポリメラーゼ連鎖反応を使用して重鎖及び軽鎖可変領域をコードするcDNAを特異的に増幅した。重鎖可変領域はIgG2発現ベクターにクローニングした。このベクターはヒトIgG2の定常領域をpcDNA3.1+/Hygro(Invitrogen,Burlington,ON)のマルチクローニング部位にクローニングすることにより作製した。軽鎖可変領域はIgK発現ベクターにクローニングした。このベクターはヒトIgKの定常領域をpcDNA3.1+/Neo(Invitrogen,Burlington,ON)のマルチクローニング部位にクローニングすることにより作製した。次に重鎖及び軽鎖発現ベクターの適当な対を70%コンフルエントヒト胚性腎293細胞の60mm皿にコリポフェクションし、トランスフェクト細胞に組換え抗体を24時間分泌させた。上清(3mL)をHEK293細胞から回収し、ヒトIgGを特異的に検出するサンドイッチELISAで無傷抗体(AB−ABT2−XG2−012及びAB−ABT2−XG2−198)の分泌を確認した(表5,第4列)。ELISAを使用して組換え抗体とビオチン化とEpoRの結合によりAB−ABT2−XG2−012とAB−ABT2−XG2−198の特異性を確認した(表5,第5列)。
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/269,711 US20040071694A1 (en) | 2002-10-14 | 2002-10-14 | Erythropoietin receptor binding antibodies |
US10/684,109 US7396913B2 (en) | 2002-10-14 | 2003-10-10 | Erythropoietin receptor binding antibodies |
PCT/US2003/032243 WO2004035603A2 (en) | 2002-10-14 | 2003-10-14 | Erythropoietin receptor binding antibodies |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009029449A Division JP2009149665A (ja) | 2002-10-14 | 2009-02-12 | エリスロポエチン受容体結合抗体 |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2006523083A JP2006523083A (ja) | 2006-10-12 |
JP2006523083A5 true JP2006523083A5 (ja) | 2009-04-02 |
JP4411472B2 JP4411472B2 (ja) | 2010-02-10 |
Family
ID=32109805
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004544846A Expired - Fee Related JP4411472B2 (ja) | 2002-10-14 | 2003-10-14 | エリスロポエチン受容体結合抗体 |
JP2009029449A Pending JP2009149665A (ja) | 2002-10-14 | 2009-02-12 | エリスロポエチン受容体結合抗体 |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2009029449A Pending JP2009149665A (ja) | 2002-10-14 | 2009-02-12 | エリスロポエチン受容体結合抗体 |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP1578779A4 (ja) |
JP (2) | JP4411472B2 (ja) |
KR (1) | KR20050059263A (ja) |
CN (1) | CN103524618A (ja) |
AU (2) | AU2003282588B2 (ja) |
BR (1) | BR0315275A (ja) |
CA (1) | CA2501984C (ja) |
MX (1) | MXPA05003997A (ja) |
NZ (1) | NZ539263A (ja) |
PL (1) | PL379985A1 (ja) |
TW (1) | TWI320716B (ja) |
WO (1) | WO2004035603A2 (ja) |
ZA (1) | ZA201004902B (ja) |
Families Citing this family (94)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002356844C1 (en) * | 2001-10-23 | 2010-03-04 | Amgen Fremont Inc. | PSMA antibodies and protein multimers |
AR045563A1 (es) | 2003-09-10 | 2005-11-02 | Warner Lambert Co | Anticuerpos dirigidos a m-csf |
HUE024962T2 (en) * | 2004-02-06 | 2016-02-29 | Univ Massachusetts | Antibodies to Clostridium difficile toxins and their uses |
US20050227289A1 (en) * | 2004-04-09 | 2005-10-13 | Reilly Edward B | Antibodies to erythropoietin receptor and uses thereof |
CA2701032C (en) | 2007-09-27 | 2021-01-26 | Amgen Inc. | Pharmaceutical formulations |
WO2009064838A1 (en) | 2007-11-15 | 2009-05-22 | Amgen, Inc. | Aqueous formulation of erythropoiesis stimulating protein stablised by antioxidants for parenteral administration |
EP2574628B1 (en) | 2008-01-25 | 2015-05-20 | Amgen Inc. | Ferroportin antibodies and methods of use |
WO2009139822A1 (en) | 2008-05-01 | 2009-11-19 | Amgen Inc. | Anti-hepcidin antibodies and methods of use |
JP2012500818A (ja) * | 2008-08-28 | 2012-01-12 | エフ.ホフマン−ラ ロシュ アーゲー | ヒトepo受容体に対する抗体 |
CN102215869B (zh) | 2008-11-13 | 2015-05-13 | 通用医疗公司 | 用于通过调整bmp-6来调节铁稳态的方法和组合物 |
CN102282174B (zh) | 2009-01-15 | 2014-02-26 | 弗·哈夫曼-拉罗切有限公司 | 抗人epo受体的抗体 |
AU2010310457B2 (en) | 2009-10-23 | 2015-07-02 | Amgen Inc. | Vial adapter and system |
KR20180037303A (ko) | 2010-06-07 | 2018-04-11 | 암젠 인크 | 약물 전달 장치 |
CA2831100C (en) | 2011-03-31 | 2020-02-18 | Mark Dominis Holt | Vial adapter and system |
CA2833748C (en) | 2011-04-20 | 2019-07-16 | Amgen Inc. | Autoinjector apparatus |
WO2012171996A1 (en) | 2011-06-15 | 2012-12-20 | F. Hoffmann-La Roche Ag | Anti-human epo receptor antibodies and methods of use |
PT3045189T (pt) | 2011-10-14 | 2018-07-23 | Amgen Inc | Injetor e método de montagem |
MX2015006343A (es) | 2012-11-21 | 2015-10-05 | Amgen Inc | Dispositivo de administracion de farmacos. |
JP6768501B2 (ja) | 2013-03-15 | 2020-10-14 | アムゲン・インコーポレーテッド | 薬物カセット、自動注入機、および自動注入機システム |
EP2968760B1 (en) | 2013-03-15 | 2024-01-03 | Amgen Inc. | Drug cassette, autoinjector, and autoinjector system |
ES2695166T3 (es) | 2013-03-15 | 2019-01-02 | Intrinsic Lifesciences Llc | Anticuerpos antihepcidina y usos de los mismos |
KR102287687B1 (ko) | 2013-03-22 | 2021-08-06 | 암젠 인크 | 인젝터 및 조립 방법 |
JP7086520B2 (ja) | 2013-10-24 | 2022-06-20 | アムジエン・インコーポレーテツド | インジェクター及び組み立ての方法 |
EP3501575B1 (en) | 2013-10-24 | 2021-12-01 | Amgen Inc. | Drug delivery system with temperature-sensitive-control |
US10994112B2 (en) | 2014-02-05 | 2021-05-04 | Amgen Inc. | Drug delivery system with electromagnetic field generator |
WO2015171777A1 (en) | 2014-05-07 | 2015-11-12 | Amgen Inc. | Autoinjector with shock reducing elements |
KR20230037063A (ko) | 2014-06-03 | 2023-03-15 | 암겐 인코포레이티드 | 제어 가능한 약물 전달 시스템 및 사용 방법 |
WO2016049036A1 (en) | 2014-09-22 | 2016-03-31 | Intrinsic Lifesciences Llc | Humanized anti-hepcidin antibodies and uses thereof |
WO2016061220A2 (en) | 2014-10-14 | 2016-04-21 | Amgen Inc. | Drug injection device with visual and audio indicators |
EP3233159B1 (en) | 2014-12-19 | 2020-03-04 | Amgen Inc. | Drug delivery device with live button or user interface field |
ES2898469T3 (es) | 2014-12-19 | 2022-03-07 | Amgen Inc | Dispositivo de administración de medicamentos con sensor de proximidad |
EP3556411B1 (en) | 2015-02-17 | 2021-06-30 | Amgen Inc. | Drug delivery device with vacuum assisted securement and/or feedback |
EP3981450A1 (en) | 2015-02-27 | 2022-04-13 | Amgen, Inc | Drug delivery device having a needle guard mechanism with a tunable threshold of resistance to needle guard movement |
WO2017039786A1 (en) | 2015-09-02 | 2017-03-09 | Amgen Inc. | Syringe assembly adapter for a syringe |
WO2017100501A1 (en) | 2015-12-09 | 2017-06-15 | Amgen Inc. | Auto-injector with signaling cap |
CN105542006A (zh) * | 2015-12-11 | 2016-05-04 | 北京大学第一医院 | 抗epor融合蛋白抗体的制备方法和用途 |
US11154661B2 (en) | 2016-01-06 | 2021-10-26 | Amgen Inc. | Auto-injector with signaling electronics |
EP3429663B1 (en) | 2016-03-15 | 2020-07-15 | Amgen Inc. | Reducing probability of glass breakage in drug delivery devices |
US11541168B2 (en) | 2016-04-29 | 2023-01-03 | Amgen Inc. | Drug delivery device with messaging label |
US11389588B2 (en) | 2016-05-02 | 2022-07-19 | Amgen Inc. | Syringe adapter and guide for filling an on-body injector |
WO2017197222A1 (en) | 2016-05-13 | 2017-11-16 | Amgen Inc. | Vial sleeve assembly |
WO2017200989A1 (en) | 2016-05-16 | 2017-11-23 | Amgen Inc. | Data encryption in medical devices with limited computational capability |
WO2017209899A1 (en) | 2016-06-03 | 2017-12-07 | Amgen Inc. | Impact testing apparatuses and methods for drug delivery devices |
US11285266B2 (en) | 2016-07-01 | 2022-03-29 | Amgen Inc. | Drug delivery device having minimized risk of component fracture upon impact events |
WO2018034784A1 (en) | 2016-08-17 | 2018-02-22 | Amgen Inc. | Drug delivery device with placement detection |
EP3532127A1 (en) | 2016-10-25 | 2019-09-04 | Amgen Inc. | On-body injector |
AU2018210301A1 (en) | 2017-01-17 | 2019-08-01 | Amgen Inc. | Injection devices and related methods of use and assembly |
CA3048520A1 (en) | 2017-02-17 | 2018-08-23 | Amgen Inc. | Drug delivery device with sterile fluid flowpath and related method of assembly |
MX2019009755A (es) | 2017-02-17 | 2019-10-07 | Amgen Inc | Mecanismo de insercion para dispositivo de suministro de farmacos. |
MX2019010544A (es) | 2017-03-06 | 2019-10-21 | Amgen Inc | Dispositivo de administracion de farmacos con caracteristica de prevencion de la activacion. |
SG11201908058UA (en) | 2017-03-07 | 2019-09-27 | Amgen Inc | Needle insertion by overpressure |
SG11201908062QA (en) | 2017-03-09 | 2019-09-27 | Amgen Inc | Insertion mechanism for drug delivery device |
EP3570871B1 (en) | 2017-03-20 | 2020-11-18 | H. Hoffnabb-La Roche Ag | Method for in vitro glycoengineering of an erythropoiesis stimulating protein |
LT3600491T (lt) | 2017-03-28 | 2023-10-10 | Amgen Inc. | Stūmoklio koto ir švirkšto konstrukcinė sistema ir būdas |
AU2018282077B2 (en) | 2017-06-08 | 2023-11-23 | Amgen Inc. | Torque driven drug delivery device |
AU2018280054B2 (en) | 2017-06-08 | 2023-07-13 | Amgen Inc. | Syringe assembly for a drug delivery device and method of assembly |
US11541183B2 (en) | 2017-06-22 | 2023-01-03 | Amgen Inc. | Device activation impact/shock reduction |
CA3063921A1 (en) | 2017-06-23 | 2018-12-27 | Amgen Inc. | Electronic drug delivery device comprising a cap activated by a switch assembly |
JP7408398B2 (ja) | 2017-07-14 | 2024-01-05 | アムジエン・インコーポレーテツド | 二重ねじりばねシステムを有する針挿入後退システム |
JP2020527376A (ja) | 2017-07-21 | 2020-09-10 | アムジエン・インコーポレーテツド | 薬物容器のためのガス透過性シーリング部材及び組立方法 |
EP4085942A1 (en) | 2017-07-25 | 2022-11-09 | Amgen Inc. | Drug delivery device with gear module and related method of assembly |
EP3658206A1 (en) | 2017-07-25 | 2020-06-03 | Amgen Inc. | Drug delivery device with container access system and related method of assembly |
US20200164155A1 (en) | 2017-08-09 | 2020-05-28 | Amgen Inc. | Hydraulic-pneumatic pressurized chamber drug delivery system |
EP3668567A1 (en) | 2017-08-18 | 2020-06-24 | Amgen Inc. | Wearable injector with sterile adhesive patch |
US11103636B2 (en) | 2017-08-22 | 2021-08-31 | Amgen Inc. | Needle insertion mechanism for drug delivery device |
WO2019070472A1 (en) | 2017-10-04 | 2019-04-11 | Amgen Inc. | FLOW ADAPTER FOR MEDICATION DELIVERY DEVICE |
MA50614A (fr) | 2017-10-06 | 2020-08-12 | Amgen Inc | Dispositif d'administration de médicament comprenant un ensemble de verrouillage et procédé d'assemblage associé |
WO2019074579A1 (en) | 2017-10-09 | 2019-04-18 | Amgen Inc. | DRUG DELIVERY DEVICE COMPRISING A DRIVE ASSEMBLY AND ASSEMBLY METHOD THEREOF |
US11826480B2 (en) | 2017-11-03 | 2023-11-28 | Amgen Inc. | Systems and approaches for sterilizing a drug delivery device |
US20200261648A1 (en) | 2017-11-06 | 2020-08-20 | Amgen Inc. | Drug delivery device with placement and flow sensing |
US20200338271A1 (en) | 2017-11-06 | 2020-10-29 | Amgen Inc. | Fill-finish assemblies and related methods |
AU2018364933B2 (en) | 2017-11-10 | 2024-01-25 | Amgen Inc. | Plungers for drug delivery devices |
MX2020005066A (es) | 2017-11-16 | 2020-08-20 | Amgen Inc | Autoinyector con deteccion de detencion y punto final. |
JP7370969B2 (ja) | 2017-11-16 | 2023-10-30 | アムジエン・インコーポレーテツド | 薬物送達デバイスの扉ラッチ機構 |
US10835685B2 (en) | 2018-05-30 | 2020-11-17 | Amgen Inc. | Thermal spring release mechanism for a drug delivery device |
US11083840B2 (en) | 2018-06-01 | 2021-08-10 | Amgen Inc. | Modular fluid path assemblies for drug delivery devices |
WO2020023336A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Hybrid drug delivery devices with grip portion |
US20210260279A1 (en) | 2018-07-24 | 2021-08-26 | Amgen Inc. | Hybrid drug delivery devices with optional grip portion and related method of preparation |
MA53379A (fr) | 2018-07-24 | 2021-06-02 | Amgen Inc | Dispositifs d'administration pour l'administration de médicaments |
CA3103682A1 (en) | 2018-07-24 | 2020-01-30 | Amgen Inc. | Delivery devices for administering drugs |
EP3829692A1 (en) | 2018-07-31 | 2021-06-09 | Amgen Inc. | Fluid path assembly for a drug delivery device |
MA53724A (fr) | 2018-09-24 | 2021-12-29 | Amgen Inc | Systèmes et procédés de dosage interventionnel |
US20210228811A1 (en) | 2018-09-28 | 2021-07-29 | Amgen Inc. | Muscle wire escapement activation assembly for a drug delivery device |
CN112805048B (zh) | 2018-10-02 | 2023-09-22 | 安进公司 | 具有内部力传递的用于药物递送的注射系统 |
MA53818A (fr) | 2018-10-05 | 2022-01-12 | Amgen Inc | Dispositif d'administration de médicament ayant un indicateur de dose |
EA202191038A1 (ru) | 2018-10-15 | 2021-07-06 | Эмджен Инк. | Способ платформенной сборки для устройства доставки лекарственного средства |
EP3866890A1 (en) | 2018-10-15 | 2021-08-25 | Amgen Inc. | Drug delivery device having damping mechanism |
TWI831847B (zh) | 2018-11-01 | 2024-02-11 | 美商安進公司 | 部分針頭縮回之藥物遞送裝置及其操作方法 |
CA3113076A1 (en) | 2018-11-01 | 2020-05-07 | Amgen Inc. | Drug delivery devices with partial drug delivery member retraction |
WO2020091956A1 (en) | 2018-11-01 | 2020-05-07 | Amgen Inc. | Drug delivery devices with partial drug delivery member retraction |
WO2020219482A1 (en) | 2019-04-24 | 2020-10-29 | Amgen Inc. | Syringe sterilization verification assemblies and methods |
EP4017560A2 (en) | 2019-08-23 | 2022-06-29 | Amgen, Inc | Drug delivery device with configurable needle shield engagement components and related methods |
CN117320964A (zh) | 2021-05-21 | 2023-12-29 | 美国安进公司 | 优化药物容器的灌装方案的方法 |
WO2024094457A1 (en) | 2022-11-02 | 2024-05-10 | F. Hoffmann-La Roche Ag | Method for producing glycoprotein compositions |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1990008822A1 (en) * | 1989-02-03 | 1990-08-09 | Genetics Institute, Inc. | Erythropoietin receptor |
US5885574A (en) * | 1994-07-26 | 1999-03-23 | Amgen Inc. | Antibodies which activate an erythropoietin receptor |
AU6163196A (en) * | 1995-06-07 | 1996-12-30 | Smithkline Beecham Corporation | Method for obtaining receptor agonist antibodies |
AU3492497A (en) * | 1996-06-21 | 1998-01-07 | Arris Pharmaceutical Corporation | Bivalent molecules that form an activating complex with an erythropoietin receptor |
US6103879A (en) * | 1996-06-21 | 2000-08-15 | Axys Pharmaceuticals, Inc. | Bivalent molecules that form an activating complex with an erythropoietin receptor |
EP1169352A4 (en) * | 1999-04-14 | 2005-05-04 | Smithkline Beecham Corp | ANTIBODY AGAINST THE ERYTHROPOIETIN RECEPTOR |
-
2003
- 2003-10-13 TW TW092128277A patent/TWI320716B/zh not_active IP Right Cessation
- 2003-10-14 CA CA2501984A patent/CA2501984C/en not_active Expired - Fee Related
- 2003-10-14 JP JP2004544846A patent/JP4411472B2/ja not_active Expired - Fee Related
- 2003-10-14 WO PCT/US2003/032243 patent/WO2004035603A2/en active Search and Examination
- 2003-10-14 CN CN201110126552.3A patent/CN103524618A/zh active Pending
- 2003-10-14 MX MXPA05003997A patent/MXPA05003997A/es active IP Right Grant
- 2003-10-14 AU AU2003282588A patent/AU2003282588B2/en not_active Ceased
- 2003-10-14 BR BR0315275-8A patent/BR0315275A/pt not_active Application Discontinuation
- 2003-10-14 PL PL379985A patent/PL379985A1/pl not_active Application Discontinuation
- 2003-10-14 NZ NZ539263A patent/NZ539263A/en not_active IP Right Cessation
- 2003-10-14 EP EP03774776A patent/EP1578779A4/en not_active Withdrawn
- 2003-10-14 KR KR1020057006487A patent/KR20050059263A/ko not_active Application Discontinuation
-
2009
- 2009-02-12 JP JP2009029449A patent/JP2009149665A/ja active Pending
-
2010
- 2010-07-12 ZA ZA2010/04902A patent/ZA201004902B/en unknown
- 2010-09-02 AU AU2010214778A patent/AU2010214778A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2006523083A5 (ja) | ||
US20240018224A1 (en) | Anti-gpc3 antibody | |
JP6913209B2 (ja) | インターロイキン1α抗体及び有用な方法 | |
AU2018286623B2 (en) | Identification of polynucleotides associated with a sample | |
US20210403585A1 (en) | Car t-cell therapy directed to lhr for the treatment of solid tumors | |
JP4648382B2 (ja) | 抗cea、抗cd3及び抗cd28の遺伝子組み換えによる糸状な単鎖の三重特異性抗体 | |
JP4208942B2 (ja) | 金結合性タンパク質 | |
Chen et al. | Characterization of a soluble B7-H3 (sB7-H3) spliced from the intron and analysis of sB7-H3 in the sera of patients with hepatocellular carcinoma | |
JP2018042573A5 (ja) | ||
JP2016026303A5 (ja) | ||
JP2009240300A (ja) | 遺伝子組換え抗体の製造方法 | |
CN111748032B (zh) | 抗新型冠状病毒的抗体和使用该抗体的免疫检测 | |
JP6656243B2 (ja) | 細胞表面での非共有結合Fcドメイン含有タンパク質ディスプレイの方法及びそのスクリーニング方法 | |
JP2004512006A5 (ja) | ||
Scholler et al. | Method for generation of in vivo biotinylated recombinant antibodies by yeast mating | |
WO2011102342A1 (ja) | 抗体固定化担体、抗体固定化担体の製造方法および当該抗体固定化担体の利用 | |
Zöller et al. | Cutting an NKG2D ligand short: cellular processing of the peculiar human NKG2D ligand ULBP4 | |
Guzman et al. | Cattle MIC is a ligand for the activating NK cell receptor NKG2D | |
Youinou | New target antigens for antiendothelial cell antibodies | |
Butler et al. | Engineering a natural ligand-based CAR: directed evolution of the stress-receptor NKp30 | |
CN113004395B (zh) | 抗新型冠状病毒的单克隆抗体及其在免疫检测中的应用 | |
WO2019177173A1 (ja) | CADM1 v9認識抗体 | |
WO2002074904A3 (en) | Rearranged squamous cell carcinoma antigen genes ii | |
Boswell et al. | Application of B cell immortalization for the isolation of antibodies and B cell clones from vaccine and infection settings | |
EP4076509A1 (en) | Antigen-binding domain binding to psma |